About BiotecEra

BiotecEra, Inc. is a biotechnology corporation founded in 2014 by Dr. Yajun Yan and Dr. Yuheng Lin. The headquater of the company is located in the campus of the University of Georgia (UGA) at Athens, Georgia. BiotecEra is a resident company of the UGA Inovation Gateway Incubator, funded by National Science Foundation (NSF) and Georgia Research Alliance (GRA). The company is dedicated in development and commercialization of innovative microbial technologies for manufacture of valuable small molecules, including pharmaceuticals, commodity chemicals and biofuels in an efficient, economic and environmental friendly way. 

Ideas make differences

Founders

                                Dr. YAJUN YAN

Dr. Yan, associate professor of BioChemical Engineering at the University of Georgia. He has 13 years’ experience in various biotechnology research areas including protein engineering, metabolic engineering, and synthetic biology. He has published extensively on establishing microbial platforms for the production of biofuels, renewable chemicals and high-value chemicals. The research work in his lab at the University of Georgia has led to 35 journal publications and 8 patents or provisional patents. 

                              Dr. YUHENG LIN

Dr. Lin, Chief Technology Officer of BiotecEra, Inc. He received his Ph.D. degree in Biological and Agricultural Engineering from the University of Georgia in 2014. His research has been focusing on microbiology, metabolic engineering, bio-catalysis and bioconversion. He has published 22 journal articles and 5 patents/ provisional patents in his fields of endeavor. Some of the technologies he developed is being commercialized by BiotecEra.

Scientific Advisors

Dr. MICHAEL W. ADAMS

Dr. Adams, Georgia Power Professor of Biotechnology and Distinguished Research Professor in the Biochemistry and Molecular Biology Department at UGA. His research has focused on anaerobic microorganisms, particularly hyperthermophiles. The research projects in his laboratory involve studying the physiology, metabolism, enzymology and functional genomics of these organisms. He has been using some hyperthermophilic organisms that are able to directly breakdown plant biomass to generate biofuels and chemicals via metabolic engineering approaches. He has been on the scientific advisory board of several biotechnology companies such as Gate Fuels, Inc.

 

 

 

Dr. QIPENG YUAN

Dr. Yuan, Distinguished Professor and Changjiang Scholar of Beijing University of Chemical Technology, College of Life Science and Technology. He has outstanding achievements in the field of bio-pharmaceuticals, natural product research and development, and genetic engineering drugs. Many of his research projects have been commercialized and applied by world-renown brands. He as the primary contributor was awarded the second prize of national scientific and technological progress in China. He served as a consultant or advisor for many biotech companies.

 

 

 

Business Advisors

Mr. Stefan Schulze

Stefan Schulze, MBA, Associate Director of the University of Georgia’s biotechnology business incubator, the Georgia BioBusiness Center (GBBC). He has worked with over 40 startup companies either emerging from UGA research or leasing space within the GBBC incubator facility. Stefan joined the GBBC staff in 2008 after several years as a Research Scientist. Stefan is currently managing over 10 active GRA Ventures seed grant projects centering on proof of concept studies and market analyses. The technologies at the base of these companies come from many different disciplines including microbial and plant biotechnology, engineering, biofuels, infectious disease vaccines and therapeutics, research tools, and agriculture products. As a mentor for early stage startup teams, Stefan has participated in several technology entrepreneurship training programs including the Kauffman Foundation’s Fast Trac Tech Venture and the National Science Foundation’s iCorps program. He has also served as a mentor for the SEBIO Investor Forum’s BioPlan and Early Stage Venture competition.